Error loading player: No playable sources found
5365
Clinical Practice Updates: Battle of the Heavyweights
Date
May 21, 2024
Society: AGA
LIVE STREAM SESSION This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format. This 90-minute symposium will feature 3 debates among "heavyweight" faculty who will provide greater clarity as to how we can apply best evidence to clinical decision-making for these challenging topics. Debates focus on recently published AGA Clinical Practice Updates, which are evidence-based reviews and commentaries that address evolving areas of clinical practice and/or technology. These documents address topics of very high clinical importance, and are published in AGA's flagship journals Gastroenterology and CGH.
LIVE STREAM SESSION This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format. This 90-minute symposium will feature 3 debates among "heavyweight" faculty who will provide greater clarity as to how we can apply best evidence to clinical decision-making for these challenging topics. Debates focus on recently published AGA Clinical Practice Updates, which are evidence-based reviews and commentaries that address evolving areas of clinical practice and/or technology. These documents address topics of very high clinical importance, and are published in AGA's flagship journals Gastroenterology and CGH.
Moderators
University of Virginia Health System
Mayo Clinic in Florida
Related Products
Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
DEVELOPMENT AND VALIDATION OF THE HOPE-EVL SCORE: A SCORING SYSTEM FOR IN-HOSPITAL MORTALITY FOLLOWING BAND LIGATION IN ESOPHAGEAL VARICEAL BLEEDING
FDA Town Hall
SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…
